Across TCGA pan-cancer cohorts, RPS26P58 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RPS26P58’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where RPS26P58 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS26P58 is over-expressed in tumor, although a few such as HNSC show the opposite, repressed pattern.

LIHC, COAD, and HNSC are the cancer types where RPS26P58 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS26P58 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	All	+0.231	.002	3	view →
COAD	Female	II,III,IV	+0.682	.021	2	view →
HNSC	Female	II,III,IV	−0.336	.041	2	view →
KIRC	All	All	+0.254	.005	2	view →
LUSC	All	All	+0.244	.032	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: RPS26P58 RNA expression & survival · all RPS26P58 data types